검색어 : 통합검색[Beumer Antoinette]
총 5건 중 5건 출력
, 1/1 페이지
-
1
- A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
- Tan, Antoinette R.; Chan, Nancy; Kiesel, Brian F.; Stein, Mark N.; Moss, Rebecca A.; Malhotra, Jyoti; Aisner, Joseph; Shah, Mansi; Gounder, Murugesan; Lin, Hongxia; Kane, Michael P.; Lin, Yong; Ji, Jiuping; Chen, Alice; Beumer, Jan H.; Mehnert, Janice M.; ; (Cancer chemotherapy and pharmacology, v.89, 2022, pp.49-58)
-
2
- A phase I study of chronically dosed, single-agent veliparib (ABT-888) in patients (pts) with either BRCA 1/2-mutated cancer (BRCA+), platinum-refractory ovarian cancer, or basal-like breast cancer (BRCA-wt).
- Huggins-Puhalla, Shannon Leigh; Beumer, Jan Hendrik; Appleman, Leonard Joseph; Tawbi, Hussein Abdul-Hassan; Stoller, Ronald G.; Lin, Yan; Kiesel, Brian; Tan, Antoinette R.; Gibbon, Darlene; Jiang, Yixing; Garcia, Agustin; Chew, Helen K.; Morgan, Robert; Shepherd, Stacie Peacock; Giranda, Vincent L.; Chen, Alice P.; Belani, Chandra Prakash; Chu, Edward; University of Pittsburgh Cancer Institute, Magee-Womens Hospital, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; The Cancer Institute of New Jersey, New Brunswick, NJ; The Cancer Institute of New Jersey, New Brunswick, NJ; Penn State Hershey Cancer Institute, Hershey, PA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; University of California, Davis Cancer Center, Sacramento, CA; City of Hope, Duarte, CA; Abbott Laboratories, Abbott Park, IL; Abbott Laboratories, Abbott Park, IL; National Cancer Institute, Bethesda, MD; Penn State Hershey Cancer Institute, Hershey, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.30, 2012, pp.3054-3054)
-
3
- Final results of a phase 1 study of single-agent veliparib (V) in patients (pts) with either BRCA1/2-mutated cancer (BRCA+), platinum-refractory ovarian, or basal-like breast cancer (BRCA-wt).
- Puhalla, Shannon; Beumer, Jan Hendrik; Pahuja, Shalu; Appleman, Leonard Joseph; Tawbi, Hussein Abdul-Hassan; Stoller, Ronald G.; Lee, James J.; Lin, Yan; Kiesel, Brian; Yu, Jing; Tan, Antoinette R.; Belani, Chandra Prakash; Chew, Helen K.; Garcia, Agustin A.; Morgan, Robert; Giranda, Vincent L.; Shepherd, Stacie Peacock; Chen, Alice P.; Chu, Edward; University of Pittsburgh Medical Center, Women's Cancer Program at Magee-Womens Hospital of UPMC, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh, Magee-Womens Hospital of UPMC, Pittsburgh, PA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Penn State Hershey Cancer Institute, Hershey, PA; University of California, Davis, Sacramento, CA; University of Southern California, Los Angeles, CA; City of Hope, Duarte, CA; Abbott Laboratories, Abbott Park, IL; Abbott Laboratories, Abbott Park, IL; National Cance; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.2570-2570)
-
4
- Outcome of BRCA 1/2-mutated (BRCA+) and triple-negative, BRCA wild type (BRCA-wt) breast cancer patients in a phase I study of single-agent veliparib (V).
- Pahuja, Shalu; Beumer, Jan Hendrik; Appleman, Leonard Joseph; Tawbi, Hussein Abdul-Hassan; Stoller, Ronald G.; Lee, James J.; Lin, Yan; Kiesel, Brian; Yu, Jing; Tan, Antoinette R.; Belani, Chandra Prakash; Chew, Helen K.; Garcia, Agustin A.; Morgan, Robert; Chen, Alice P.; Giranda, Vincent L.; Shepherd, Stacie Peacock; Chu, Edward; Puhalla, Shannon; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Pittsburgh, Magee-Womens Hospital of UPMC, Pittsburgh, PA; National Surgical Adjuvant Breast and Bowel Project and Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Penn State Hershey Cancer Institute, Hershey, PA; University of California, Davis, Sacramento, CA; University of Southern California, Los Angeles, CA; City of Hope, Duarte, CA; National Cancer Institute at the National Institutes of Health, Bethesda, MD; Abbott Labora; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.135-135)
-
5
- A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
- Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J.; Diergaarde, Brenda; Kiesel, Brian F.; Yu, Jing; Tan, Antoinette R.; Belani, Chandra P.; Chew, Helen; Garcia, Agustin A.; Morgan, Robert J.; Wahner Hendrickson, Andrea E.; Visscher, Daniel W.; Hurley, Rachel M.; Kaufmann, Scott H.; Swisher, Elizabeth M.; Oesterreich, Steffi; Katz, Tiffany; Ji, Jiuping; Zhang, Yiping; Parchment, Ralph E.; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P.; Ivy, S. Percy; Chu, Edward; Beumer, Jan H.; ; (Cancer chemotherapy and pharmacology, v.89, 2022, pp.721-735)
1
QUICK MENU
